Mainstay Capital Management LLC Neurocrine Biosciences Inc Transaction History

Mainstay Capital Management LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Mar 04, 2021	SELL	$86.91 - $108.33 $247,345 - $308,307	-2,846 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$96.16 - $135.15 $5,769 - $8,109	-60 Reduced 2.06%	2,846 $274,000
Q2 2020 Jul 23, 2020	BUY	$85.09 - $130.36 $22,123 - $33,893	260 Added 9.83%	2,906 $354,000
Q1 2020 Apr 23, 2020	BUY	$75.11 - $113.76 $32,672 - $49,485	435 Added 19.67%	2,646 $228,000
Q4 2019 Jan 21, 2020	SELL	$86.8 - $118.57 $83,762 - $114,420	-965 Reduced 30.38%	2,211 $238,000
Q3 2019 Oct 16, 2019	SELL	$83.82 - $101.5 $1,844 - $2,233	-22 Reduced 0.69%	3,176 $288,000
Q2 2019 Aug 07, 2019	BUY	$72.24 - $91.27 $55,480 - $70,095	768 Added 31.6%	3,198 $270,000
Q1 2019 Apr 23, 2019	SELL	$69.31 - $91.53 $53,299 - $70,386	-769 Reduced 24.04%	2,430 $213,000
Q4 2018 Feb 08, 2019	SELL	$68.32 - $124.36 $69,071 - $125,727	-1,011 Reduced 24.01%	3,199 $222,000
Q3 2018 Nov 13, 2018	BUY	$98.88 - $125.85 $2,768 - $3,523	28 Added 0.67%	4,210 $518,000
Q2 2018 Aug 24, 2018	SELL	$75.3 - $105.99 $9.85 Million - $13.9 Million	-130,788 Reduced 96.9%	4,182 $411,000
Q2 2018 Aug 23, 2018	BUY	$75.3 - $105.99 $9.85 Million - $13.9 Million	130,825 Added 3156.21%	134,970 $1.62 Million
Q1 2018 May 10, 2018	SELL	$75.88 - $92.43 $45,679 - $55,642	-602 Reduced 12.68%	4,145 $343,000
Q4 2017 Mar 28, 2018	BUY	$58.53 - $77.59 $277,841 - $368,319	4,747	4,747 $368,000

627

94.3M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Mainstay Capital Management LLC , based on Form 13F filings with the SEC.

Stay updated on Mainstay Capital Management LLC with notifications on news.